EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Dynamic Contrast Enhanced—Magnetic Resonance Fingerprinting ( DCE ‐ MRF ) Improves Detection of Induced Vascular Perfusion Reduction in a Mouse Breast Cancer Model

Christina J MacAskill iD, Bernadette O Erokwu, Yuran Zhu iD, Guanhua Wang iD, Andrew Dupuis iD, Barbara J Schiemann, Gopalakrishnan Ramamurthy, Chetan B Dhakan iD, Michael Kavran, Chunying Wu, William P Schiemann, Yilun Sun und 4 weitere

Magnetic Resonance in Medicine · 2026

DOI: 10.1002/mrm.70274 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Magnetic Resonance in Medicine, 2026. Verfasst von Christina J MacAskill und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Neovascularization, Pathologic, Mammary Neoplasms, Experimental, Magnetic Resonance Imaging. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, American Heart Association, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Dynamic contrast‐enhanced MRI (DCE‐MRI) can assess tumor perfusion using pharmacokinetic models. However, poor DCE‐MRI reproducibility from reliance on conventional T 1 ‐weighted MRI has limited clinical translation. We evaluated whether Dynamic Contrast Enhanced‐Magnetic Resonance Fingerprinting (DCE‐MRF), which directly generates quantitative T 1 relaxation time constant maps, provides improved precision and statistical power for detecting treatment‐induced vascular changes compared to conventional DCE‐MRI.

Methods

Twenty female mice bearing orthotopic 4 T1 breast tumors were randomly assigned to DCE‐MRF ( n = 12) or conventional DCE‐MRI ( n = 8) cohorts. Both methods acquired matched spatial and temporal resolution (23‐s) T 1 measurements at baseline, 3 h, and 48 h post‐treatment with combretastatin A4 phosphate (120 mg/kg), a known vascular disrupting agent. Perfusion assessments were obtained with a pharmacokinetic Linear Reference Region Model ( RK trans and k ep,T ) and model‐independent initial area under the curve assessments and compared using Wilcoxon signed‐rank tests and Hedges' g effect sizes.

Results

DCE‐MRF demonstrated 1.3‐to‐5.1‐fold larger effect sizes for RK trans across all regions and timepoint comparisons, and 1.3‐to‐1.9‐fold larger effect sizes for tumor rim k ep,T compared to conventional DCE‐MRI. RK trans and k ep,T at 3 h post‐treatment in all regions, detected significant vascular recovery for whole tumor RK trans and both whole tuomor and tumor rim for k ep,T at 48 h, whereas DCE‐MRI only detected significant changes at 3 h.

Conclusions

DCE‐MRF's improved measurement precision and increased effect size translates directly to enhanced statistical power for detecting treatment‐induced vascular changes, positioning it as a more reproducible tumor perfusion assessment for animal models and eventually cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsNeovascularization, PathologicMammary Neoplasms, ExperimentalMagnetic Resonance ImagingAnimalsFemaleMiceDynamic Contrast Enhanced Magnetic Resonance ImagingStilbenesReproducibility of ResultsContrast MediaPerfusion Magnetic Resonance ImagingDisease Models, Animal

Stichwörter der Autor:innen

DCE‐MRIMR fingerprintingbreast cancerdynamic contrast enhanced MRImouse modelsperfusionpharmacokinetic modeling

Substanzen

StilbenesContrast Mediafosbretabulin

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA.
  • Department of Radiology, Case Western Reserve University, Cleveland, Ohio, USA.
  • Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan, USA.
  • Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio, USA.
  • Department of Medical Physics, University of Wisconsin, Madison, Wisconsin, USA.
  • Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio, USA.

ORCID-Profile: Christina J MacAskill, Yuran Zhu, Guanhua Wang, Andrew Dupuis, Chetan B Dhakan, Xin Yu, Mark D Pagel

Förderung

  • NIH HHS
  • American Heart Association
  • NCI NIH HHS
  • NIBIB NIH HHS
  • NCATS NIH HHS
  • NIGMS NIH HHS
  • NINDS NIH HHS
  • National Institute of General Medical Sciences

Zitieren

APA

MacAskill, C. J., Erokwu, B. O., Zhu, Y., Wang, G., Dupuis, A., Schiemann, B. J., Ramamurthy, G., Dhakan, C. B., Kavran, M., Wu, C., Schiemann, W. P., Sun, Y., Griswold, M. A., Yu, X., Pagel, M. D., & Flask, C. A. (2026). Dynamic Contrast Enhanced—Magnetic Resonance Fingerprinting ( DCE ‐ MRF ) Improves Detection of Induced Vascular Perfusion Reduction in a Mouse Breast Cancer Model. Magnetic Resonance in Medicine. https://doi.org/10.1002/mrm.70274

Vancouver

MacAskill CJ, Erokwu BO, Zhu Y, Wang G, Dupuis A, Schiemann BJ, et al. Dynamic Contrast Enhanced—Magnetic Resonance Fingerprinting ( DCE ‐ MRF ) Improves Detection of Induced Vascular Perfusion Reduction in a Mouse Breast Cancer Model. Magnetic Resonance in Medicine. 2026. doi:10.1002/mrm.70274

BibTeX
@article{MacAskill2026,
  author = {MacAskill, Christina J and Erokwu, Bernadette O and Zhu, Yuran and Wang, Guanhua and Dupuis, Andrew and Schiemann, Barbara J and Ramamurthy, Gopalakrishnan and Dhakan, Chetan B and Kavran, Michael and Wu, Chunying and Schiemann, William P and Sun, Yilun and Griswold, Mark A and Yu, Xin and Pagel, Mark D and Flask, Chris A},
  title = {Dynamic Contrast Enhanced—Magnetic Resonance Fingerprinting ( DCE ‐ MRF ) Improves Detection of Induced Vascular Perfusion Reduction in a Mouse Breast Cancer Model},
  journal = {Magnetic Resonance in Medicine},
  year = {2026},
  doi = {10.1002/mrm.70274}
}
Kostenlos starten →